Internal Medicine Alert – August 30, 2010
August 30, 2010
View Issues
-
Failing Doctors, Failing Hearts
Obstructive sleep apnea is associated with an increased risk of incident heart failure in community-dwelling middle-aged and older men, but not in women. -
β-blockers as Cardiopulmonary Agents: The Benefits May Not Be Limited to CVD
In a large, well-designed observational study of patients with COPD, treatment with β-blockers during a mean follow-up period of 7.2 years was found not only to reduce the risk of exacerbations, but also to improve survival. -
Can We Diagnose Gout Without Needling Our Patients?
Use of simply obtained historical, physical, and laboratory data can distinguish gout from other forms of arthritis in many patients and avoid joint aspiration. -
Dutasteride and Tamsulosin HCl Capsules (Jalyn™)
The FDA has approved the combination of dutasteride (DUT) and tamsulosin (TAM) in a single capsule. Dutasteride is a 5-a reductase inhibitor and tamsulosin is an a-adrenergic antagonist. The combination is marketed by GlaxoSmithKline as Jalyn™. -
Clinical Briefs by Louis Kuritzky, MD
Of late, there has been a renaissance of interest in identification and management of hypogonadism in older men.